A Food and Drug Administration (FDA) scientist who found that antidepressants may increase the risk of suicidal behaviors in children has been prohibited from making his findings public. He was asked by the FDA to write up a safety analysis about children taking the antidepressants Paxil, Effexor and others after reports of high rates of suicidal behavior among children taking such drugs surfaced early in 2003.

During his analysis he reviewed 20 clinical trialsinvolving more than 4,000 children and eight different antidepressants. In his written report, and according to two FDA sources who have read the contents, he concluded that there was a definite link between children who took antidepressants and suicidal behavior.

After learning of this finding, the FDA informed the scientist that he would not be presenting his analysis, saying it was not "finalized," but he would instead present reports received by the agency from doctors and professionals. Critics fear that the FDA’s action means they are not willing to take stronger measures against the antidepressants despite the possible effects on children. The FDA says there is a possibility that the scientist’s report may eventually be completed and made public.

According to a 2003 study in the Archives of Pediatric and Adolescent Medicine, the use of antidepressants among children has more than tripled in recent years and soon the use of these drugs will reach adult usage rates.

San Francisco Gate February 1, 2004